Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications-Reference-Cited by-同舟云学术

Association of End Point Definition and Randomized Clinical Trial Duration in Clinical Trials of Schizophrenia Medications

Published:2020-10-01 Issue:10 Volume:77 Page:1064
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Younis Islam R.¹,Gopalakrishnan Mathangi¹²,Mathis Mitchell³,Mehta Mehul¹,Uppoor Ramana¹,Zhu Hao¹,Farchione Tiffany³

Affiliation:

1. Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland

2. Center for Translational Medicine, University of Maryland, Baltimore

3. Division of Psychiatry Products, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2767296/jamapsychiatry_younis_2020_oi_200035_1601309860.15052.pdf

Reference17 articles.

1. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.;Downing;JAMA,2014

2. Schizophrenia.;Mueser;Lancet,2004

3. The economic burden of schizophrenia in the United States in 2013.;Cloutier;J Clin Psychiatry,2016

4. The economic burden of schizophrenia in the United States in 2002.;Wu;J Clin Psychiatry,2005

5. New drug developments in psychosis: Challenges, opportunities and strategies.;Keshavan;Prog Neurobiol,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial;Schizophrenia Research;2024-08

2. Non-invasive brain stimulation for treatment-resistant schizophrenia: protocol of a systematic review and network meta-analysis;Systematic Reviews;2024-06-24

3. The effect of differences in trial design on estimates of efficacy of olanzapine in randomized studies;Psychiatry Research;2024-06

4. Integrating Cognitive Competency, Social Competency and Risk Propensity with the Theory of Planned Behaviour to Attain Sustainable-Development-Goal-8-Driven Sustainable Entrepreneurial Intentions;Sustainability;2024-05-07

5. Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades;Journal of Pharmaceutical Policy and Practice;2023-09-28